|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-8-19
|
|
pubmed:abstractText |
Conventional imaging (CI) is known to have limitations with respect to staging of patients with primary or relapsed prostate cancer. Positron emission tomography/computed tomography (PET/CT) with (18)F-flurodeoxyglucose (FDG) is also often suboptimal because of low tracer avidity, but (18)F-fluorocholine (FCH) appears to be a promising alternative molecular imaging probe. We report a prospective pilot study of PET/CT comparing both tracers for staging and restaging of patients with prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1754-9485
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
325-32
|
|
pubmed:meshHeading |
pubmed-meshheading:20718912-Aged,
pubmed-meshheading:20718912-Choline,
pubmed-meshheading:20718912-Fluorodeoxyglucose F18,
pubmed-meshheading:20718912-Follow-Up Studies,
pubmed-meshheading:20718912-Humans,
pubmed-meshheading:20718912-Male,
pubmed-meshheading:20718912-Middle Aged,
pubmed-meshheading:20718912-Neoplasm Staging,
pubmed-meshheading:20718912-Pilot Projects,
pubmed-meshheading:20718912-Positron-Emission Tomography,
pubmed-meshheading:20718912-Prospective Studies,
pubmed-meshheading:20718912-Prostate,
pubmed-meshheading:20718912-Prostatic Neoplasms,
pubmed-meshheading:20718912-Radiographic Image Enhancement,
pubmed-meshheading:20718912-Radiopharmaceuticals,
pubmed-meshheading:20718912-Reproducibility of Results,
pubmed-meshheading:20718912-Sensitivity and Specificity,
pubmed-meshheading:20718912-Tomography, X-Ray Computed
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.
|
|
pubmed:affiliation |
Centre for Molecular Imaging, Department of Cancer Imaging, University of Melbourne, Melbourne, Australia.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
